General mechanism of spider toxin family I acting on sodium channel Nav1.7

被引:0
|
作者
Fu-Chu Yuan [1 ]
Fu-De Sun [2 ]
Lin Zhang [1 ]
Biao Huang [3 ]
Hai-Long An [2 ]
Ming-Qiang Rong [1 ]
Can-Wei Du [3 ]
机构
[1] National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University
[2] Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Science & Biomedical Engineering,Hebei University of Technology
[3] Chengdu Pepbiomedical Co., Ltd.
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
Q958 [动物生态学和动物地理学];
学科分类号
071012 ; 0713 ;
摘要
Various peptide toxins in animal venom inhibit voltage-gated sodium ion channel Nav1.7, including Nav-targeting spider toxin(NaSpTx) Family I. Toxins in NaSpTx Family I share a similar structure, i.e., Nterminal, loops 1–4, and C-terminal. Here, we used Mu-theraphotoxin-Ca2a(Ca2a), a peptide isolated from Cyriopagopus albostriatus, as a template to investigate the general properties of toxins in NaSpTx Family I. The toxins interacted with the cell membrane prior to binding to Nav1.7 via similar hydrophobic residues. Residues in loop 1, loop 4,and the C-terminal primarily interacted with the S3–S4 linker of domain II, especially basic amino acids binding to E818. We also identified the critical role of loop 2 in Ca2a regarding its affinity to Nav1.7.Our results provide further evidence that NaSpTx Family I toxins share similar structures and mechanisms of binding to Nav1.7.
引用
收藏
页码:886 / 896
页数:11
相关论文
共 50 条
  • [31] Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7
    Xiao-yu Zhang
    Rui-yun Bi
    Peng Zhang
    Ye-hua Gan
    Acta Pharmacologica Sinica, 2018, 39 : 1716 - 1724
  • [32] NETWORK TOPOLOGY OF NAV1.7 MUTATIONS IN SODIUM CHANNEL-RELATED PAINFUL DISORDERS
    Kapetis, D.
    Yang, Y.
    Galbardi, B.
    Szklarczyk, R.
    Faber, C. G.
    Gerrits, M.
    Merkies, I. S. J.
    Dib-Hajj, S. D.
    Tononi, P.
    Sassone, J.
    Mantegazza, M.
    Waxman, S. G.
    Lauria, G.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S14 - S15
  • [33] Effect of rufinamide on gating properties of voltage-gated sodium channel Nav1.7
    Suter, M. R.
    Abriel, H.
    Decosterd, I.
    SWISS MEDICAL WEEKLY, 2010, 140 : 9S - 10S
  • [34] Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis
    Pukkanasut, Piyasuda
    Jaskula-Sztul, Renata
    Gomora, Juan Carlos
    Velu, Sadanandan E.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Sodium channel subunit β4 influences the binding of ProTx-II to Nav1.7 and Nav1.2
    Hampl, M.
    Havlicek, S.
    Winner, B.
    Lampert, A.
    ACTA PHYSIOLOGICA, 2016, 216
  • [36] Modeling the Binding of Tetrodotoxin and Saxitoxin to the Nav1.7 Voltage-Gated Sodium Channel
    Fiore, Isabella
    Mukund, Smrithi
    Buddharaju, Laasya
    Lavin, Emily Schmitt
    Sikora, Arthur
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S77 - S77
  • [37] Polysorbate 80 blocked a peripheral sodium channel, Nav1.7, and reduced neuronal excitability
    Kim, Ryeong-Eun
    Choi, Jin-Sung
    MOLECULAR PAIN, 2023, 19
  • [38] Pancreatic A-cell NaV1.7 sodium channel is involved in glucagon release in mice
    Welling, A.
    Leiss, V.
    Auer, V.
    Hofmann, F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 41 - 41
  • [39] Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7
    Zhang, Xiao-yu
    Bi, Rui-yun
    Zhang, Peng
    Gan, Ye-hua
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (11) : 1716 - 1724
  • [40] Network topology of NaV1.7 mutations in sodium channel-related painful disorders
    Kapetis, Dimos
    Sassone, Jenny
    Yang, Yang
    Galbardi, Barbara
    Xenakis, Markos N.
    Westra, Ronald L.
    Szklarczyk, Radek
    Lindsey, Patrick
    Faber, Catharina G.
    Gerrits, Monique
    Merkies, Ingemar S. J.
    Dib-Hajj, Sulayman D.
    Mantegazza, Massimo
    Waxman, Stephen G.
    Lauria, Giuseppe
    BMC SYSTEMS BIOLOGY, 2017, 11